Your browser doesn't support javascript.
loading
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.
Mota, Jose Mauricio; Collier, Katharine Ann; Barros Costa, Ricardo Lima; Taxter, Timothy; Kalyan, Aparna; Leite, Caio A; Chae, Young Kwang; Giles, Francis J; Carneiro, Benedito A.
Afiliação
  • Mota JM; Instituto do Câncer do Estado de São Paulo, Division of Oncology, Universidade de São Paulo, São Paulo, Brazil.
  • Collier KA; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Barros Costa RL; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Taxter T; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Kalyan A; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Leite CA; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Chae YK; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Giles FJ; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Carneiro BA; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Oncotarget ; 8(51): 89284-89306, 2017 Oct 24.
Article em En | MEDLINE | ID: mdl-29179520

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Brasil